DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-804 Cr |
| Mar2024 | ₹-269 Cr |
| Mar2023 | ₹-2,707 Cr |
| Mar2022 | ₹-2,195 Cr |
| Mar2021 | ₹75 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-804 Cr | Negative | |
| Mar2024 | ₹-269 Cr | Negative | |
| Mar2023 | ₹-2,707 Cr | Negative | |
| Mar2022 | ₹-2,195 Cr | Negative | |
| Mar2021 | ₹75 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹158,175.6 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
| MANKIND PHARMA | ₹84,799.1 Cr | 2.8% | -6.1% | -15.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.7% |
-5.9% |
3.9% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses